INTERLEUKIN-20 FOR TREATING AND DIAGNOSING CONDITIONS ASSOCIATED WITH NEOVASCULARISATION

摘要

Use of IL-20 or an analogue, active fragment or derivative thereof for the manufacture of a medicament for the promotion of neovascularisation. Use of an antagonist of IL-20 or an analogue, active fragment or derivative thereof for the manufacture of a medicament for the inhibition of neovascularisation. A method of diagnosing a state of disease involving neovascularisation by analysing the IL-20 activity.